Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy

Journal of Acquired Immune Deficiency Syndromes

Volumn 32, Issue 4, 2003, Pages 370-374

  Shiramizu, Bruce ^a,d   Shikuma, Kelsey M ^b   Kamemoto, Lori ^a   Gerschenson, Mariana ^a   Erdem, Guliz ^a   Pinti, Marcello ^c   Cossarizza, Andrea ^c   Shikuma, Cecilia ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d Young Building ^*  (United States)

Author keywords

Human immunodeficiency virus (HIV); Mitochondria DNA (mtDNA); Mitochondrial toxicity; Nucleoside reverse transcriptase inhibitor (NRTI) ; Pregnancy

Indexed keywords

LAMIVUDINE; MITOCHONDRIAL DNA; NELFINAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; ZIDOVUDINE;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DELIVERY; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MITOCHONDRION; MORBIDITY; PLACENTA; PREGNANCY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; SUDDEN INFANT DEATH SYNDROME; UMBILICAL CORD BLOOD; VERTICAL TRANSMISSION;

BASE SEQUENCE; DISEASE TRANSMISSION, VERTICAL; DNA PRIMERS; DNA, MITOCHONDRIAL; FEMALE; FETAL BLOOD; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; MITOCHONDRIA; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REVERSE TRANSCRIPTASE INHIBITORS; ZIDOVUDINE;

EID: 0037378552     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200304010-00004     Document Type: Article

References (24)

1. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning. A laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1982:280-283.
2. Saiki RK, Bugawan TL, Horn GT, et al. Analysis of enzymatically amplified beta-globin and HLA-DQα DNA with allele-specific oligonucleotide probes. Nature. 1986;324:163-166.
3. Cossarizza A, Pinti M, Moretti L, et al. Mitochondrial functionality and mitochondrial DNA content in lymphocytes of vertically infected human immunodeficiency virus-positive children with highly active antiretroviral therapy-related lipodystrophy. J Infect Dis. 2002;185:299-305.
4. Summary of the updated recommendations from the Public Health Service Task Force to reduce perinatal human immunodeficiency virus-1 transmission in the United States. Obstet Gynecol. 2002; 99:1117-1126.
5. Cossarizza A, Mussini C, Viganb A. Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders? Bioessays. 2001;23:1070-1080.
6. Foli A, Benvenuto F, Piccinini G, et al. Direct analysis of mitochondrial toxicity of antiretroviral drugs. AIDS. 2001;15:1687-1694.
7. Shikuma CM, Hu N, Milne C, et al. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy. AIDS. 2001;15:1801-1809.
8. Zaera MG, Miro O, Pedrol E, et al. Mitochondrial involvement in antiretroviral therapy-related lipodystrophy. AIDS. 2001;15:1643-1651.
9. Rustin P. Mitochondrial dysfunction in HIV infection: an overview of pathogenesis. J HIV Ther. 2001;6:4-12.
10. Brinkman K, ter Hofstede HJ, Burger DM, et al. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS. 1998;12:1735-1744.
11. Lewis W, Dalakas MC. Mitochondrial toxicity of antiviral drugs. Nat Med. 1995;1:417-422.
12. Cherry CL, Gahan ME, McArthur JC, et al. Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat. J Acquir Immune Defic Syndr. 2002;30:271-277.
13. Cote HC, Brumme ZL, Craib KJ, et al. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med. 2002;346:811-820.
14. Klopstock T, Naumann M, Seibel P, et al. Mitochondrial DNA mutations in multiple symmetric lipomatosis. Mol Cell Biochem. 1997;174:271-275.
15. Naumann M, Kiefer R, Toyka KV, et al. Mitochondrial dysfunction with myoclonus epilepsy and ragged-red fibers point mutation in nerve, muscle, and adipose tissue of a patient with multiple symmetric lipomatosis. Muscle Nerve. 1997;20:833-839.
16. Gerschenson M, Poirier MC. Fetal patas monkeys sustain mitochondrial toxicity as a result of in utero zidovudine exposure. Ann N Y Acad Sci. 2000;918:269-281.
17. Olivero OA, Shearer GM, Chougnet CA, et al. Incorporation of zidovudine into cord blood DNA of infants and peripheral blood DNA of their HIV-1-positive mothers. Ann N Y Acad Sci. 2000; 918:262-268.
18. Olivero OA, Shearer GM, Chougnet CA, et al. Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero. AIDS. 1999;13:919-925.
19. Blanche S, Tardieu M, Rustin P, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet. 1999;354:1084-1089.
20. Perinatal Safety Review Working Group. Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts. J Acquir Immune Defic Syndr. 2000;25:261-268.
21. Lipshultz SE, Easley KA, Orav EJ, et al. Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study. Lancet. 2002;360:368-373.
22. Lipshultz SE, Easley KA, Orav EJ, et al. Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med. 2000;343:759-766.
23. Pinti M, Nasi M, Moretti L, et al. Role of platelet contamination in assessing mtDNA content in peripheral blood mononuclear cells. Antivir Ther. 2002;7:L15.
24. Divi RL, Walker VE, Gerschenson M, et al. Mitochondrial damage in umbilical cord and cord blood lymphocytes of infants exposed in utero to zidvudine (AZT) and lamivudine (3TC). Anchorage, Alaska: Environmental Mutagen Society, 2002.